Thus, it is conceivable that CD45+CD3−CSF-1R+PD-L1+ cells that infiltrate within the tumor areas may play a stronger role in suppressing antitumor immune response in DCC than those in the peripheries of the tumors. The gene discussed is PTPRC; the disease is neoplasm.